Christina Ricci1†Divya Subburaj2†Kate Lim3*†Neetu Shukla1Jaskiran Kaur4Lin Xie1Meghan Laverty1Dianne Zakaria1Jason Pole5,6Marie-Claude Pelland-Marcotte7,8Randy Barber9Sara J. Israels10Thai-Hoa Tran11,12Sapna Oberoi10,13Samuele Renzi14,15Tamara MacDonald16,17Lillian Sung14,18Ketan Kulkarni2*1Lifespan Chronic Disease and Conditions Division, Public Health Agency of Canada, Ottawa, ON, Canada2Department of Pediatrics, Division of Hematology-Oncology, Izzak Walton Killam (IWK) Health Centre, Halifax, NS, Canada3Faculty of Medicine, Dalhousie University, Halifax, NS, Canada4Surveillance Systems and Data Management Division, Public Health Agency of Canada, Ottawa, ON, Canada5Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada6Centre for Health Sciences Research, University of Queensland, Brisbane, QLD, Australia7Division of Pediatric Hematology-Oncology, CHU de Québec-Centre Mère-Enfant Soleil, Quebec City, QC, Canada8Research Centre of the CHU de Québec, Axe Reproduction, Santé de la Mère et de l’Enfant, Quebec City, QC, Canada9C17 Research Network, C17 Council, Edmonton, AB, Canada10Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada11Department of Pediatrics, Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, QC, Canada12Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada13Department of Pediatric Hematology-Oncology, CancerCare Manitoba, Winnipeg, MB, Canada14Division of Hematology Oncology, The Hospital for Sick Children, Toronto, ON, Canada15Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy16Department of Pharmacy, Izzak Walton Killam (IWK) Health, Halifax, NS, Canada17Faculty of Health Professions, Dalhousie University, Halifax, NS, Canada18Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada

In the published article, there was an error in the legend for Figure 5 to 7 as published. Currently it stated “This hazard ratio has been suppressed because less than 5 patients have the characteristic.” The corrected legend appears below.

“ƚ indicates this hazard ratio has been suppressed because less than 5 patients have the characteristic.”

Figure 5 Forest plot depicting the variables and adjusted hazard ratio for SMN. ƚ indicates this hazard ratio has been suppressed because less than 5 patients have the characteristic.

Figure 6 Forest plot depicting the variables and adjusted hazard ratio for SMN developed within 0-2 years. ƚ indicates this hazard ratio has been suppressed because less than 5 patients have the characteristic.

Figure 7 Forest plot depicting the variables and adjusted hazard ratio for SMN developed within 2-5 years. ƚ indicates this hazard ratio has been suppressed because less than 5 patients have the characteristic.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: oncology, pediatrics, risk factors, early second malignant neoplasm (early SMN), Canada, surveillance

Citation: Ricci C, Subburaj D, Lim K, Shukla N, Kaur J, Xie L, Laverty M, Zakaria D, Pole J, Pelland-Marcotte M-C, Barber R, Israels SJ, Tran T-H, Oberoi S, Renzi S, MacDonald T, Sung L and Kulkarni K (2024) Corrigendum: Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study. Front. Oncol. 14:1418512. doi: 10.3389/fonc.2024.1418512

Received: 16 April 2024; Accepted: 22 April 2024;
Published: 10 May 2024.

Copyright © 2024 Ricci, Subburaj, Lim, Shukla, Kaur, Xie, Laverty, Zakaria, Pole, Pelland-Marcotte, Barber, Israels, Tran, Oberoi, Renzi, MacDonald, Sung and Kulkarni. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Kate Lim, kate.lim@dal.ca; Ketan Kulkarni, Ketan.Kulkarni@iwk.nshealth.ca

†These authors share first authorship